Anti-sclerostin constructs and uses thereof

The present application provides anti-Sclerostin constructs that bind to Sclerostin (e.g., anti-Sclerostin antibodies, e.g., bispecific anti-Sclerostin antibodies), nucleic acid molecules encoding an amino acid sequence of the anti-Sclerostin, vectors comprising the nucleic acid molecules, host cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIU Xiaofeng, LIU Kunfeng, LI Muyu, KE Huazhu, YUAN Baozhi
Format: Patent
Sprache:eng ; heb
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LIU Xiaofeng
LIU Kunfeng
LI Muyu
KE Huazhu
YUAN Baozhi
description The present application provides anti-Sclerostin constructs that bind to Sclerostin (e.g., anti-Sclerostin antibodies, e.g., bispecific anti-Sclerostin antibodies), nucleic acid molecules encoding an amino acid sequence of the anti-Sclerostin, vectors comprising the nucleic acid molecules, host cells containing the vectors, methods of preparing the anti-Sclerostin construct, pharmaceutical compositions containing the anti-Sclerostin construct, and methods of using the anti-Sclerostin construct or compositions.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL301763A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL301763A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL301763A3</originalsourceid><addsrcrecordid>eNrjZNB2zCvJ1C1Ozkktyi8uycxTSM7PKy4pKk0uKVZIzEtRKC1OLVYoyUgtSs1P42FgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8Z4-xgaG5mbGjsYEFQAAntgokw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Anti-sclerostin constructs and uses thereof</title><source>esp@cenet</source><creator>LIU Xiaofeng ; LIU Kunfeng ; LI Muyu ; KE Huazhu ; YUAN Baozhi</creator><creatorcontrib>LIU Xiaofeng ; LIU Kunfeng ; LI Muyu ; KE Huazhu ; YUAN Baozhi</creatorcontrib><description>The present application provides anti-Sclerostin constructs that bind to Sclerostin (e.g., anti-Sclerostin antibodies, e.g., bispecific anti-Sclerostin antibodies), nucleic acid molecules encoding an amino acid sequence of the anti-Sclerostin, vectors comprising the nucleic acid molecules, host cells containing the vectors, methods of preparing the anti-Sclerostin construct, pharmaceutical compositions containing the anti-Sclerostin construct, and methods of using the anti-Sclerostin construct or compositions.</description><language>eng ; heb</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230501&amp;DB=EPODOC&amp;CC=IL&amp;NR=301763A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230501&amp;DB=EPODOC&amp;CC=IL&amp;NR=301763A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LIU Xiaofeng</creatorcontrib><creatorcontrib>LIU Kunfeng</creatorcontrib><creatorcontrib>LI Muyu</creatorcontrib><creatorcontrib>KE Huazhu</creatorcontrib><creatorcontrib>YUAN Baozhi</creatorcontrib><title>Anti-sclerostin constructs and uses thereof</title><description>The present application provides anti-Sclerostin constructs that bind to Sclerostin (e.g., anti-Sclerostin antibodies, e.g., bispecific anti-Sclerostin antibodies), nucleic acid molecules encoding an amino acid sequence of the anti-Sclerostin, vectors comprising the nucleic acid molecules, host cells containing the vectors, methods of preparing the anti-Sclerostin construct, pharmaceutical compositions containing the anti-Sclerostin construct, and methods of using the anti-Sclerostin construct or compositions.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB2zCvJ1C1Ozkktyi8uycxTSM7PKy4pKk0uKVZIzEtRKC1OLVYoyUgtSs1P42FgTUvMKU7lhdLcDHJuriHOHrqpBfnxqcUFicmpeakl8Z4-xgaG5mbGjsYEFQAAntgokw</recordid><startdate>20230501</startdate><enddate>20230501</enddate><creator>LIU Xiaofeng</creator><creator>LIU Kunfeng</creator><creator>LI Muyu</creator><creator>KE Huazhu</creator><creator>YUAN Baozhi</creator><scope>EVB</scope></search><sort><creationdate>20230501</creationdate><title>Anti-sclerostin constructs and uses thereof</title><author>LIU Xiaofeng ; LIU Kunfeng ; LI Muyu ; KE Huazhu ; YUAN Baozhi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL301763A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; heb</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LIU Xiaofeng</creatorcontrib><creatorcontrib>LIU Kunfeng</creatorcontrib><creatorcontrib>LI Muyu</creatorcontrib><creatorcontrib>KE Huazhu</creatorcontrib><creatorcontrib>YUAN Baozhi</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LIU Xiaofeng</au><au>LIU Kunfeng</au><au>LI Muyu</au><au>KE Huazhu</au><au>YUAN Baozhi</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Anti-sclerostin constructs and uses thereof</title><date>2023-05-01</date><risdate>2023</risdate><abstract>The present application provides anti-Sclerostin constructs that bind to Sclerostin (e.g., anti-Sclerostin antibodies, e.g., bispecific anti-Sclerostin antibodies), nucleic acid molecules encoding an amino acid sequence of the anti-Sclerostin, vectors comprising the nucleic acid molecules, host cells containing the vectors, methods of preparing the anti-Sclerostin construct, pharmaceutical compositions containing the anti-Sclerostin construct, and methods of using the anti-Sclerostin construct or compositions.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; heb
recordid cdi_epo_espacenet_IL301763A
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Anti-sclerostin constructs and uses thereof
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T22%3A09%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LIU%20Xiaofeng&rft.date=2023-05-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL301763A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true